DEVELOPMENT OF B CELL MATURATION ANTIGEN (BCMA)-SPECIFIC CD8+ CYTOTOXIC T LYMPHOCYTES USING INDUCED PLURIPOTENT STEM CELL TECHNOLOGY FOR MULTIPLE MYELOMA

被引：0
|
作者：
Bae, Jooeun [1 ]
Kitayama, Shuichi [1 ]
Herbert, Zach [1 ,2 ]
Daheron, Laurence [2 ]
Munshi, Nikhil [1 ]
Ritz, Jerome [1 ]
Kaneko, Shin [3 ]
Anderson, Kenneth [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA USA
[2] Harvard Univ, Cambridge, MA USA
[3] Kyoto Univ, Kyoto, MA USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷
关键词：
D O I：
10.1136/jitc-2022-SITC2022.1220
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1220
引用
收藏
页码：A1265 / A1265
页数：1
相关论文
共 50 条
  • [1] Development of B-cell maturation antigen (BCMA)-specific CD8+ cytotoxic T lymphocytes using induced pluripotent stem cell technology for multiple myeloma
    Bae, Jooeun
    Kitayama, Shuichi
    Herbert, Zach
    Daheron, Laurence
    Munshi, Nikhil C.
    Kaneko, Shin
    Ritz, Jerome
    Anderson, Kenneth Carl
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [2] Selective targeting of multiple myeloma by B cell maturation antigen (BCMA)-specific central memory CD8+ cytotoxic T lymphocytes: immunotherapeutic application in vaccination and adoptive immunotherapy
    Bae, Jooeun
    Samur, Mehmet
    Richardson, Paul
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    LEUKEMIA, 2019, 33 (09) : 2208 - 2226
  • [3] Selective targeting of multiple myeloma by B cell maturation antigen (BCMA)-specific central memory CD8+ cytotoxic T lymphocytes: immunotherapeutic application in vaccination and adoptive immunotherapy
    Jooeun Bae
    Mehmet Samur
    Paul Richardson
    Nikhil C. Munshi
    Kenneth C. Anderson
    Leukemia, 2019, 33 : 2208 - 2226
  • [4] Rejuvenated BCMA-specific CD8ab+memory T cells to treat multiple myeloma using induced pluripotent stem cell technology
    Bae, Jooeun
    Kitayama, Shuichi
    Herbert, Zach
    Daheron, Laurence
    Kurata, Keiji
    Munshi, Nikhil
    Kaneko, Shin
    Anderson, Kenneth
    ANNALS OF ONCOLOGY, 2023, 34 : S1389 - S1390
  • [5] Rejuvenated BCMA-Specific CD8 + Cytotoxic T Lymphocytes Derived from Antigen-Specific Induced Pluripotent Stem Cells : Immunotherapeutic Application in Multiple Myeloma
    Bae, Jooeun
    Kitayama, Shuichi
    Daheron, Laurence
    Herbert, Zach
    Munshi, Nikhil C.
    Kaneko, Shin
    Ritz, Jerome
    Anderson, Kenneth C.
    BLOOD, 2021, 138
  • [6] Rejuvenated BCMA-specific CD8+Cytotoxic T lymphocytes derived from induced pluripotent stem cells for treatment of Multiple Myeloma
    Bae, Jooeun
    Kitayama, Shuichi
    Daheron, Laurence
    Herbert, Zach
    Munshi, Nikhil C.
    Ritz, Jerome
    Kaneko, Shin
    Anderson, Kenneth
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S84 - S84
  • [7] Immunotherapeutic application of induced pluripotent stem cell technology: Rejuvenated BCMA-specific CD8+T cells for multiple myeloma.
    Bae, Jooeun
    Kitayama, Shuichi
    Herbert, Zach
    Daheron, Laurence
    Munshi, Nikhil
    Kaneko, Shin
    Ritz, Jerome
    Anderson, Kenneth
    CANCER RESEARCH, 2022, 82 (12)
  • [8] Selective Targeting of Multiple Myeloma By Bcma-Specific Central Memory CD8+ cytotoxic T Lymphocytes: A Potential Immunotherapeutic Application in Multiple Myeloma and Other Plasma Cell Disorders
    Bae, Jooeun
    Hideshima, Teru
    Munshi, Nikhil
    Anderson, Kenneth C.
    BLOOD, 2018, 132
  • [9] B cell maturation antigen (BCMA)-based immunotherapy for multiple myeloma
    Tai, Yu-Tzu
    Anderson, Kenneth C.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (11) : 1143 - 1156
  • [10] Bcma Heteroclitic Peptide Encapsulated Nanoparticle Enhances Antigen Stimulatory Capacity and Tumor-Specific CD8+ cytotoxic T Lymphocytes Against Multiple Myeloma
    Bae, Jooeun
    Neha, Parayath
    Amiji, Mansoor
    Munshi, Nikhil
    Anderson, Kenneth
    BLOOD, 2018, 132
12345